“Unleashing the Promise of Biotechnology: Advancing American Innovation to Cure Disease...
BIO commends the House of Representatives for including provisions intended to ease small...
An Objective Definition of Small Company in Sarbanes-Oxley Rules Would Lessen the Compliance...
Jim Greenwood released the following statement following a vote today by the U.S. Securities...
The changes proposed by the Securities and Exchange Commission (SEC) and the Public Companies...
BIO reiterates support as Senate Small Business Committee considers changes.
The biotechnology industry, hard-hit by the complex and burdensome regulations imposed by...
BIO President and CEO Jim Greenwood today commented on reports that the Securities and Exchange...
Jim Greenwood issued the following remarks regarding comments submitted Tuesday by BIO and a...
Jim Greenwood issued the following statement in response to the Securities and Exchange...
Subscribe to Our Newsletter